Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Veresen Inc.
T.VSN.DB.B
Energy
Oil & Gas Midstream
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:VSN.DB.B)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(16)
•••
RipCrackle
X
View Profile
View Bullboard History
Comment by
RipCrackle
on May 01, 2017 9:29am
RE:RE:Good or Bad
If I read between the lines then I think what they're saying is that the merged company would have a better shot at building and supplying Jordan Cove. Either way I will likely take the shares
...more
(1)
•••
rocket800
X
View Profile
View Bullboard History
Post by
rocket800
on May 01, 2017 9:24am
Thoughts
The Q is due out this week I believe. I feel there was going to be an good response in the SP. I think they wanted this news out before the release.
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(16)
•••
Macmckim
X
View Profile
View Bullboard History
Comment by
Macmckim
on May 01, 2017 9:06am
RE:Good or Bad
I also think the buyout number is low. If Veresen had approval on Jordon Cover project, the share price would have been in the low $20. The PPL would be offering in mid to high $20's.&
...more
(4)
•••
check737
X
View Profile
View Bullboard History
Post by
check737
on May 01, 2017 8:57am
Good or Bad
This doesn't sound like enough of a premium to me. What do others think? Who else might be interested in VSN?
(20)
•••
scarface9
X
View Profile
View Bullboard History
Comment by
scarface9
on May 01, 2017 7:52am
RE:Buyout by ppl
"This Transaction is highly strategic for Pembina and Veresen alike, providing clear visibility to creating long-term value for our respective shareholders," said Mr. Randy Findlay , Pembina
...more
(5)
•••
Zynder
X
View Profile
View Bullboard History
Post by
Zynder
on May 01, 2017 6:57am
Buyout by ppl
Looks like a buyout buy ppl. Over 18.50 per share coming.
(131)
•••
hawk35
X
View Profile
View Bullboard History
Comment by
hawk35
on Apr 28, 2017 8:41pm
RE:RE:Bruce Campbell's Top Pick
Hey bobo. Don't read too much into the recent share price drop. Markets move up and down every day. This stock is a winner for the long haul.
(0)
•••
bobo2000
X
View Profile
View Bullboard History
Comment by
bobo2000
on Apr 27, 2017 8:07pm
RE:Bruce Campbell's Top Pick
Not sure I would lend much credence to Campbell's picks. Look at the record of some of his previous choices. Not going to prosper following his advice. He picks it yesterday and it drops over a
...more
(3)
•••
lotus1
X
View Profile
View Bullboard History
Post by
lotus1
on Apr 27, 2017 6:42am
Bruce Campbell's Top Pick
BNN Market Call Tonight April 25, 2017 Bruce Campbell, president and portfolio manager at StoneCastle Investment Management, shares his top picks: Veresen Inc The company is a leading
...more
(0)
•••
Olderguy
X
View Profile
View Bullboard History
Comment by
Olderguy
on Apr 26, 2017 2:48pm
RE:Down
Veresen is viewed as over-bought in some circles, which is why I think there has been a minor selloff. Last year at this time, Veresen was trading at around $8.50. Keeping that in mind will make us
...more
(0)
•••
bobo2000
X
View Profile
View Bullboard History
Post by
bobo2000
on Apr 26, 2017 12:04pm
Down
Down today substantially and no apparent reason. Positvie press and no prob with divi - what gives?
(0)
•••
Olderguy
X
View Profile
View Bullboard History
Post by
Olderguy
on Apr 26, 2017 11:06am
Bloomberg Report
There was positive reference to Veresen in a Bloomberg report today titled "Liquefied Natural Gas Is All the Rage in the Trump Administration" Some lines from the article... - Gary Cohn
...more
(3)
•••
lotus1
X
View Profile
View Bullboard History
Post by
lotus1
on Apr 24, 2017 9:00am
CIBC
CIBC Institutional Equity Research April 21, 2017 Veresen Inc. Cohn Hints At Federal Support For Jordan Cove LNG Conclusion Support from the U.S. Presidential administration for permitting of
...more
(7)
•••
sitttingbull
X
View Profile
View Bullboard History
Post by
sitttingbull
on Apr 23, 2017 11:18pm
From Encana news release...Veresen projects
..They are apparently ahead of schedule.... quote: "Beginning in the fourth quarter of 2017 and continuing into 2018, new midstream infrastructure and downstream capacity is expected to unlock
...more
(7)
•••
sitttingbull
X
View Profile
View Bullboard History
Post by
sitttingbull
on Apr 20, 2017 9:45pm
Veresen mentiond again
Heres the link https://www.bloomberg.com/news/articles/2017-04-20/white-house-s-cohn-wants-to-see-more-and-more-lng-terminals
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Discover a Green Resources Stock Scoring Record Quarterly Growth